Eriksson, Henry

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

Schulman, S., Kearon, C., Kakkar, A. K., Schellong, S., Eriksson, H., Baanstra, D., Kvamme, A. M., Friedman, J., Mismetti, P., & Goldhaber, S. Z. (2013) · New England Journal of Medicine

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes

Cited by 983

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Schulman, S., Kakkar, A. K., Goldhaber, S. Z., Schellong, S., Eriksson, H., Mismetti, P., Christiansen, A. V., Friedman, J., Le Maulf, F., Peter, N., et al. (2014) · Circulation

Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes

Cited by 923

Recurrent Venous Thromboembolism After Deep Vein Thrombosis: Incidence and Risk Factors

Hansson, P.-O., Sörbo, J., & Eriksson, H. (2000) · Archives of Internal Medicine

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 590

Heart failure in the general population of men - morbidity, risk factors and prognosis

Wilhelmsen, L., Rosengren, A., Eriksson, H., & Lappas, G. (2001) · Journal of Internal Medicine

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 315

Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER ® , RE-COVER™ II, and RE-MEDY™

Goldhaber, S. Z., Eriksson, H., Kakkar, A., Schellong, S., Feuring, M., Fraessdorf, M., Kreuzer, J., Schueler, E., & Schulman, S. (2016) · Vascular Medicine

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

Cited by 89